Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fluarix Quadrivalent
Vaccines
GSK, Seqirus begin shipping flu vaccines for the 2018-19 season
Seqirus expects to offer 50 million flu vaccine doses, while GSK plans to boost its supplies to 40 million to 45 million, its highest total ever.
Angus Liu
Aug 14, 2018 11:49am
GSK's Fluarix protects young children in large phase 3 test
Mar 7, 2018 8:40am
Egg allergies are no reason to pass on flu shots, guidelines say
Dec 19, 2017 7:40pm
Bexsero propels GSK's vaccines unit to 16% growth in Q1
May 1, 2017 6:44am
UPDATED: Protein Sciences sets sights on quadrivalent flu vax market
Oct 17, 2016 1:55pm
GSK yanks all doses of quadrivalent flu jab for potency problems
Apr 20, 2015 11:11am
